368 related articles for article (PubMed ID: 26087188)
1. Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells.
Poh AR; O'Donoghue RJ; Ernst M
Oncotarget; 2015 Jun; 6(18):15752-71. PubMed ID: 26087188
[TBL] [Abstract][Full Text] [Related]
2. Insights on hematopoietic cell kinase: An oncogenic player in human cancer.
Luo S; Du S; Tao M; Cao J; Cheng P
Biomed Pharmacother; 2023 Apr; 160():114339. PubMed ID: 36736283
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Hematopoietic Cell Kinase Activity Suppresses Myeloid Cell-Mediated Colon Cancer Progression.
Poh AR; Love CG; Masson F; Preaudet A; Tsui C; Whitehead L; Monard S; Khakham Y; Burstroem L; Lessene G; Sieber O; Lowell C; Putoczki TL; O'Donoghue RJJ; Ernst M
Cancer Cell; 2017 Apr; 31(4):563-575.e5. PubMed ID: 28399411
[TBL] [Abstract][Full Text] [Related]
4. Hck tyrosine kinase regulates TLR4-induced TNF and IL-6 production via AP-1.
Smolinska MJ; Page TH; Urbaniak AM; Mutch BE; Horwood NJ
J Immunol; 2011 Dec; 187(11):6043-51. PubMed ID: 22021612
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis: HCK in erythropoietin/PI3K pathway.
Roversi FM; Pericole FV; Machado-Neto JA; da Silva Santos Duarte A; Longhini AL; Corrocher FA; Palodetto B; Ferro KP; Rosa RG; Baratti MO; Verjovski-Almeida S; Traina F; Molinari A; Botta M; Saad ST
Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):450-461. PubMed ID: 27840303
[TBL] [Abstract][Full Text] [Related]
6. Selective targeting of the inactive state of hematopoietic cell kinase (Hck) with a stable curcumin derivative.
Chakraborty MP; Bhattacharyya S; Roy S; Bhattacharya I; Das R; Mukherjee A
J Biol Chem; 2021; 296():100449. PubMed ID: 33617879
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine-phosphorylated STAT5 accumulates on podosomes in Hck-transformed fibroblasts and chronic myeloid leukemia cells.
Poincloux R; Cougoule C; Daubon T; Maridonneau-Parini I; Le Cabec V
J Cell Physiol; 2007 Oct; 213(1):212-20. PubMed ID: 17503465
[TBL] [Abstract][Full Text] [Related]
8. The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion.
Je DW; O YM; Ji YG; Cho Y; Lee DH
Pancreas; 2014 Jul; 43(5):768-76. PubMed ID: 24763074
[TBL] [Abstract][Full Text] [Related]
9. Ribotoxic stress response to the trichothecene deoxynivalenol in the macrophage involves the SRC family kinase Hck.
Zhou HR; Jia Q; Pestka JJ
Toxicol Sci; 2005 Jun; 85(2):916-26. PubMed ID: 15772366
[TBL] [Abstract][Full Text] [Related]
10. Hck inhibitors as potential therapeutic agents in cancer and HIV infection.
Musumeci F; Schenone S; Brullo C; Desogus A; Botta L; Tintori C
Curr Med Chem; 2015; 22(13):1540-64. PubMed ID: 25666803
[TBL] [Abstract][Full Text] [Related]
11. Src family tyrosine kinases phosphorylate Flt3 on juxtamembrane tyrosines and interfere with receptor maturation in a kinase-dependent manner.
Mitina O; Warmuth M; Krause G; Hallek M; Obermeier A
Ann Hematol; 2007 Nov; 86(11):777-85. PubMed ID: 17668209
[TBL] [Abstract][Full Text] [Related]
12. Src family kinases, HCK and FGR, associate with local inflammation and tumour progression in colorectal cancer.
Roseweir AK; Powell AGMT; Horstman SL; Inthagard J; Park JH; McMillan DC; Horgan PG; Edwards J
Cell Signal; 2019 Apr; 56():15-22. PubMed ID: 30684564
[TBL] [Abstract][Full Text] [Related]
13. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.
Moarefi I; LaFevre-Bernt M; Sicheri F; Huse M; Lee CH; Kuriyan J; Miller WT
Nature; 1997 Feb; 385(6617):650-3. PubMed ID: 9024665
[TBL] [Abstract][Full Text] [Related]
14. The proto-oncogene p120(Cbl) is a downstream substrate of the Hck protein-tyrosine kinase.
Howlett CJ; Bisson SA; Resek ME; Tigley AW; Robbins SM
Biochem Biophys Res Commun; 1999 Apr; 257(1):129-38. PubMed ID: 10092522
[TBL] [Abstract][Full Text] [Related]
15. The Src-Family Kinases Hck and Fgr Regulate Early Lipopolysaccharide-Induced Myeloid Cell Recruitment into the Lung and Their Ability To Secrete Chemokines.
Mazzi P; Caveggion E; Lapinet-Vera JA; Lowell CA; Berton G
J Immunol; 2015 Sep; 195(5):2383-95. PubMed ID: 26232427
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the SRC Kinase HCK Impairs STAT3-Dependent Gastric Tumor Growth in Mice.
Poh AR; Dwyer AR; Eissmann MF; Chand AL; Baloyan D; Boon L; Murrey MW; Whitehead L; O'Brien M; Lowell CA; Putoczki TL; Pixley FJ; O'Donoghue RJJ; Ernst M
Cancer Immunol Res; 2020 Apr; 8(4):428-435. PubMed ID: 31992566
[TBL] [Abstract][Full Text] [Related]
17. Re-arrangements of podosome structures are observed when Hck is activated in myeloid cells.
Poincloux R; Vincent C; Labrousse A; Castandet J; Rigo M; Cougoule C; Bordier C; Le Cabec V; Maridonneau-Parini I
Eur J Cell Biol; 2006 Apr; 85(3-4):327-32. PubMed ID: 16546576
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic cell kinase (Hck) isoforms and phagocyte duties - from signaling and actin reorganization to migration and phagocytosis.
Guiet R; Poincloux R; Castandet J; Marois L; Labrousse A; Le Cabec V; Maridonneau-Parini I
Eur J Cell Biol; 2008 Sep; 87(8-9):527-42. PubMed ID: 18538446
[TBL] [Abstract][Full Text] [Related]
19. Activation of src-related tyrosine kinases by IL-3.
Anderson SM; Jorgensen B
J Immunol; 1995 Aug; 155(4):1660-70. PubMed ID: 7636226
[TBL] [Abstract][Full Text] [Related]
20. Expression and tyrosine phosphorylation of Cbl regulates macrophage chemokinetic and chemotactic movement.
Caveggion E; Continolo S; Pixley FJ; Stanley ER; Bowtell DD; Lowell CA; Berton G
J Cell Physiol; 2003 May; 195(2):276-89. PubMed ID: 12652654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
